Birmingham Biotechnology Hub

Lead Agency: Birmingham Bio Innovation Corporation

State Served: Alabama

Applicant-Defined Region: Birmingham–Hoover MSA with statewide partnerships

Core Technology Area: AI-driven biotechnology

Contact: Dr. Kathy Nugent ([email protected])

The Birmingham Biotechnology Hub is building a stronger U.S. foundation for drug discovery and next‑generation medicines by combining biotechnology with advanced data and AI tools. Led by the Birmingham Bio Innovation Corporation, the Hub draws on regional strengths in clinicogenomic data, human‑relevant testing systems, and applied machine learning to improve how potential treatments are identified, evaluated, and prepared for development.

By integrating these capabilities into a coordinated system, the Hub aims to make drug discovery more efficient, more predictive, and more representative of patient populations. This work strengthens the domestic infrastructure needed to advance new medicines, supports biotechnology entrepreneurs, and expands the technical workforce. Through this effort, the Birmingham Biotechnology Hub seeks to enhance U.S. competitiveness in biomedical innovation and contribute to more resilient and effective pathways for developing future therapeutics.

Additional Designations Earned in Region